The Current Ratio as of November 2024 (TTM) for Aura Biosciences, Inc. (AURA) is 18.54

According to Aura Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 18.54. This represents a change of 1.06% compared to the average of 18.35 of the last 4 quarters.

Aura Biosciences, Inc. (AURA) Historical Current Ratio (quarterly & annually)

How has AURA Current Ratio performed in the past?

The mean historical Current Ratio of Aura Biosciences, Inc. over the last ten years is 14.21. The current 18.54 Current Ratio has changed 12.95% with respect to the historical average. Over the past ten years (40 quarters), AURA's Current Ratio was at its highest in in the March 2021 quarter at 29.44. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Aura Biosciences, Inc. (AURA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Aura Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aura Biosciences, Inc. (AURA) Average Current Ratio

How has AURA Current Ratio performed in the past?

The current Current Ratio of Aura Biosciences, Inc. (AURA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Aura Biosciences, Inc. (AURA) Current Ratio vs. Peers

How is AURA’s Current Ratio compared to its peers?

Aura Biosciences, Inc.’s Current Ratio is greater than Aerovate Therapeutics, Inc. (6.51), greater than Adagene Inc. (2.50), greater than Acrivon Therapeutics, Inc. Common Stock (16.16), greater than Rezolute, Inc. (13.39), greater than AN2 Therapeutics, Inc. (10.61), greater than Seer, Inc. (17.59), greater than ORIC Pharmaceuticals, Inc. (15.08), greater than Anebulo Pharmaceuticals, Inc. (13.46), less than Cullinan Oncology, Inc. (28.87), greater than C4 Therapeutics, Inc. (6.31), greater than Crinetics Pharmaceuticals, Inc. (16.09), greater than ALX Oncology Holdings Inc. (4.39), greater than Immatics N.V. (3.74), greater than BioAtla, Inc. (3.81), greater than Opthea Limited (2.94),

Build a custom stock screener for Aura Biosciences, Inc. (AURA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aura Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aura Biosciences, Inc. (AURA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aura Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.